| Trial ID: | L1198 |
| Source ID: | NCT00410449
|
| Associated Drug: |
Alpha Tocopherol
|
| Title: |
Oxidative Stress and Hemodialysis Access Failure
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease|Hemodialysis
|
| Interventions: |
DRUG: Alpha tocopherol
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Collaborators: Leonard B Rosenberg Renal Research Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
35
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2001-05
|
| Completion Date: |
2004-05
|
| Results First Posted: |
|
| Last Update Posted: |
2015-10-06
|
| Locations: |
Center for Dialysis Care, Cleveland, Ohio, 44106, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00410449
|
